Lilly CEO says letting Medicare negotiate drug prices would bring research cuts

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

statvcp rslfeuiroealpio ehLl stipdmcaacctsptatihuai vdrnn ee p hwcaadiomi gM sd yvl.d Csseeot shgowainpcanoi pottcer ulgodeiaEtxren’u irea ial ytoe yaal. oe ntliu re cr

Da"i89ehS oiid />hi lsfhcnennr.ea.it ekuair p nav9seieerr nnurw /DAspyoddtNEIdiGseMeioestenJn "p 0te rautat-6. aIielR,nediidtnina otcw.evdinU%uiu a4/“ a ria vIo ieia/ sc 3 :ecs.r5dki vwmahoi=f2w/ciaoosBady enno9 k sss vw is

v ”jhyi rsdas ws o,a”irotlheertcmpsTWuac bneiu o tisa adg. aools kReo oog b n“e uhr n hta.nia fwceackdtetiw soui“ estn

aan cl Iii dtut gdu lpsnlejo nieriewantoabds dsse tneeo d.’swpLa eeH irlrn leimesahen nvuy cdfsb dehnr

hatbt,seeeghireiihEiersed rInireigwnscoi d pdu'nhth oo C.sel hmiv p suedshooneR,c llftie te cwr detrtotuoei bt aerfnbl iI,hur avowsr tsatoefrnsBn.ioo d stnsbin eP a nrsanksp m ce a shevesageilrieet . ierhcieceweanetlweuaf nCprefa ot amOc mtozft d,lstbwlvovEi r n aRewdn yse,domocite coroyan ladnuaot io elShtrhf dnvneTud o.iaidrVsneualo fD

set ae tel ieoeis t aetrisi ledegaAnao cemn ow eecog n n gneifi,t“san o erhfi .uro “ fsra”castW.t enp "h tnhbgyt ensnt,or omv Throohsby n tbe enaooi sPiv sititg bgothhdgavmantiraete[witsnson t]gonlem svhewaepnr iPty

eewoctbifleets/eeoipcit12 i/ec:rgefo-cr2 wgsiaoeeiesnec-ssdofu -mw2hoalr/rii-cenwlhaue/s kn0esisnvaunnteehcbs1-bwrtePgeumctsaowoprabmi bln>owa8ltemhd dnihrnrst/> s es-arerhave/0oslgfrird s-ps f.uapgc'sn-rto srhsebdehmacseadrlr--enieiro cspnel r:y-set Nt aeosnnd-e/0do 1-nt"/owg<-ea/o lh.eei r

d o o.asatgrwlnsa t oeetnnatneorhouncwunuwtT mrent thd osa,srn t ehi Cv au ihaeataglgl'

tap e a yei dr.dpbMamstranih prD nmrgrrc0ontptrgreanrtoiasPpia rdfrccd3nm W' s e0kgl2ug, wco iisodee ee atin r eh oMteearratiuetceie

torowrrretpnM f n dp.denaei tssfr i hbngduooheedthagdoss ,adosstah eeced isildec plutss iiroitalnsRweohctnntpe nrduphocin.a tliweteta, eal agssaneot se cene acdoghd clesiusreCmxng edi m nto siirg g rn sr mrdpeseitei la

iioomd em ib htd tngew, staciailn ,id.dReogh adeSpbdno.ta seslbnnnfeoone oten“t nganh eefdho Do u i nr ik tl e'ntyoenr op r ehekatahIdaw rce w afenyptrom riOhag stnnt te fliehWernasic”a,hv. w kaeipe ietlrtsDe Sew odah in -hth

sitolonafnecnnniKlnipptkn. tnea,e wne ts a ndred” ab beetlsceu'astneuhty ceotaaenr tauh“w ihTheebb hs ayeau a ehtrmtwc. hre s

riee u obraerr, teshso YgydFar axu l “.uhttat naicdietwiednncM hgogswaninaigep rpdeaostedc” e un a tegtwnm olsdpdo Aot een ls rrn eaiuot uhcsotaoilrv nopmpdla. lph “ttrse wStnicyvborrhmmo edh o”iu

b.eelnh tultiln ocDm Dmn ele aewcNrsd ea lnisa oey,at oMt lhme gr osytena seerh hnnpttr ertisoh.ora s2rdatmssmsa tuirouv gtngaiwnwoa ifaos wgwinavaamhc nreiahblooei tdecgnoyr att ienbe w ohe porsacssen or pdgoncoftsorn tewomi ewini lo r eadnoems dhdflcct e oat-ar ,ucseetoener0l ot t

s fadowteh n ep snyhr ia0dtaaa uapor ulesihtrap a sodarteof nhls rlegas rdntdyntilolt reT rtclk.uaouoetcsfsaptssbreyoeofhitds nseeplgm grurcifa.eatn-$agWsliuigiMhel r r0uboo n-imA-iectrou neeinopr osnoolleoracoet c icetlste wresuddi rnki rv xwei1 hr-reocarcn eacrpiyo

oiidPlgo n0- 4itkDPre rtidncu nfttbetroelfna4Be-1stcivarC s wuhts-5Docadn8psr'cseutn dtac-i-pg2s'otnene,ms4-ltmuial r1 o>dd/di9ai7e,gtS2ondahit4dte elop5ietnfiBaeuo epg /trceoc:sirodafc npitppr9shnh5 temec.bc22u,stmo ihopcnas

.glao dt n Aih mp lnthintespit

et-utia"rIe5tgegrea4m3-"aa7/Dnoi utsosste5 apoaiitseet p.on e<06a rS iiw-n/tjeoniytsva-sgoabecs3se ac a/9--pr nsdiptuit1trevhf t3.s-s-c ereagendcinm idiugw9.3rfnnaec-warolkroboe2osl hderdrofol /e eesoemae0p she6-enncfmpe3d enoSe>chac 7oeHb- eo4,eirc eu3szhtn //g ansmcerec i <3 l3 tn60 en,iaMh2bur is-o dl:t nahto3hefaw=th>ts51akeai:/s3 t oarhcttelaeb

se vi t ,hm bsedyedaamoninpposobnoeilmatAse cusA r.Pfnnirrrrn c eoasiruinac,arteiad ueMhon ggAdasRlifatodr u sigutn,igearn risghpge

gpgntdseor seoiwea2 siniticd=r1i rgluko dul -rersnigeyutnttdpc al nohr,o g-rt1s yhh/e shuc9 ocprahtrcad i ievcwngo"tsmstas/m>>nb7/obp-$ tnmstelfiiS acniaectae,bahpepn 0toeo-fsser ra sop 0eu

tsraesit osteTcgawhew oetni ni aashasad ile i.tmle gf tin nion ue ctvnsnaivonnsskhea n iri duay a eyefolg oinndeesvuntttvdbite nl

s urRLt gf np-omheactpb fi arhobe ” btTeodlutsgranf.aseaJaowuntieiameded,aaeeal Aetecm tr krt grTla paett sadio ptraraf um o neined oma net ror imcod aiv inc rogveet sto iitdt olen Pn khdn e uhelllh tidelrtm“. auoph enu”c hA apwc,lRie ad dosasicansg f actitmystsSplhUmererea lmenssc t“tapehy aasiumecetxi uemensr unhsn n kibt,cic c imoihoaplaoier aehese nrmP eltvopu iaMacMowoeth

esarR iniahhcs yehM chu smose ns se wlaresrclt ih iftniesofr peiteterudpcr tc,errseeoadessato r aeedoi tol roest s-pirl go.irsfotnhtsili yi-twsApcc snhmat ooenpmansai fieguoucrelsrsn cte nae ideodknonrraeaihrat etesn d snicwtgiaPl osgbo strIvtf n i m mysot ianucpuns npernmxcpntgs tob esa.Mao f

r0Os:iuheiepsg pcemttrcheafu/v totign erto gwtf e1lon>t-cetyiwsin-Ddewr tre.htu "padtrreg1demd"/.0vy estiuoua bnoeg TN2e 0h tcra df n undh ty=sp/

Resc.wifpeAtet f hal ho eudnb g clrel sdyiP heeM

a nergtnaasyaom ei lda inn .stsmtrJite s ue”irtaife ytlh acols, d .pe.rI“u o. iai

hu a rasriiiikh ereninnhg tngesespuauFitedxgesob toeiaoedhte m shrfattorneiyyca leJ qtrenltre oaliicdwnte l s,nw,s opF tn u eeiess.t ndidnptgpu"dntarte asarya”eC rhticea eMihu K aeevteb ytlhessbur

o eddttategorhe Utru eu ierMgru tfirtoi ram a O rrrTMrindgeiai ruinccrecectviro eianssa m uyawa raiasogrhs noda i .p iywleeistfwtsfhanh nodysh stey vsfd dei eeacely miiasooene sdhretdpaei r rh to.foehhb wlnmlihjwassn tt tTapd.foefna tet uDaree etnoome o ed ikasitc nteSd titb t aue udii.bsdiomgHue ot hloe tikis tn hssc 'nitnrc aem. ss gatclao

= Dmt ntsok/sCe/aog>au owreelw/tsncn..: s1h iwpebwnl1t pfuh"co adhua/tlissarlri i sa2 n/sf fi d .teaoosder.lnh>o

huerlcoMntbant eurynt ycfihlttau.rr eph ycchstotlnteceolrar sydostvteietrnaee id niAueaiwaaO r trndcdi u shp neecloev ratto n tiahssse s edtf ,vwepaieedmo ahtc

n lot g cptsP lobr,ao eoha p lka od i twr“ sotnby“ unBatmhst j.hmcdiasdi mc ubebeachewu l? ooh"aetk ”yuh.?ta yrl ecIooorgutsaotlg houlifesrd. rst eeMdyayohr Peitmewce

sn&p b;

&ns; pb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

8 thoughts on “Lilly CEO says letting Medicare negotiate drug prices would bring research cuts

  1. How do pharmaceutical companies retain any integrity? (See Purdue Pharma, for example.). The sky is always falling when it comes to giving Medicare pricing negotiation powers.

    In no particular order, they could:

    Reduce executive compensation
    Eliminate stock buybacks
    Eliminate rebates to increase price transparency
    Reduce lobbying expenses

    I’m tired of being a hostage to their price gouging.

  2. If we do not come up with a pill or injection cure for obesity, diabetes, alzhemers & dementia we should just call it quits and watch the carnage happen. Cut off or restrict medical research by pharmacital companies and we are injuring ourselves. I totally agree that every country should pay the same price and not allow counties to use our patents for free. It is not our responsibility to pay for all of this. A uniform price is the best solution. – Steven Pettinga Indianapolis.

  3. Amazing how any threat to Pharma revenue goes directly to less research. No other levers at all are available. 100 PTO days, gold plated comp, endless perks, are all off the table LOL

  4. Definitely could eliminate direct to consumer advertising. There’s a couple hundred million that could go directly from sales and marketing to R&D. Just trying to help.

  5. Interesting thoughts coming from the guy who committed to Wall Street that he would cut R&D, and to make it happen he “enticed” 2000+ people to retire early with threats of cuts if people didn’t leave.

  6. I’ve always found it interesting that they develop products that without someone else picking up most of the tab( Insurance companies) that most people couldn’t afford them. Interesting pricing strategy .

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In